Abstract
The hepatorenal syndrome is characterized by a combination of liver cirrhosis, ascites and renal impairment. It is divided into two typs, whereby typ I is defined as acute with a doubling of creatinine within 2 weeks and type II as a more modest decline of kidney function. The only definite therapy so far is transplantation. However, based on pathophysiological considerations a number of strategies have been applied. Aldosteronantagonists are the backbone of therapy even in cases of poor diuresis. Additional benefit is derived from a combination of vasopressors and albumine.
Titel in Übersetzung | The hepatorenal syndrome |
---|---|
Originalsprache | Deutsch |
Seiten (von - bis) | 1520-1523 |
Seitenumfang | 4 |
Fachzeitschrift | Deutsche Medizinische Wochenschrift |
Jahrgang | 140 |
Ausgabenummer | 20 |
DOIs | |
Publikationsstatus | Veröffentlicht - 1 Okt. 2015 |
Schlagwörter
- hepatorenal syndrome
- pathophysiology
- therapy